All-China Women’s Federation, Goldman Sachs and Susan G. Komen for the Cure® Announce Breast Cancer Education and Awarenes

BEIJING, China--(BUSINESS WIRE)-- The Goldman Sachs Group, Inc., the All-China Women’s Federation (ACWF) and Susan G. Komen for the Cure® (Komen) announced their collaboration on a pilot program in China to increase breast cancer awareness through education and training.

Goldman Sachs Gives, a donor-advised charitable fund, is committing funds to the three-year program.

Goldman Sachs and the ACWF will collaborate with Komen, leveraging their expertise to promote breast cancer awareness, breast health education and training, and explore ways to build effective localized programs that can be replicated throughout China.

J. Michael Evans, Vice Chairman of Goldman Sachs, Chairman of Goldman Sachs Asia Pacific and Global Head of Growth Markets, announced the initiative at a dinner on the occasion of the U.S.-China Women’s Leadership Exchange and Dialogue (Women-LEAD).

Mr. Evans said the initiative with the ACWF and Komen will establish a collaborative platform to promote breast cancer education and awareness. Goldman Sachs, the ACWF and Komen share a common goal to work together and contribute to improving the health of breast cancer patients in China, he added.

Increased awareness and education will lead to early detection of breast cancer, resulting in better chances of recovery and survival,” said Ms. Meng Xiaosi, Vice President of the ACWF. The ACWF launched a three-year pilot program in 2009 with the Ministry of Health for breast and cervical cancer screening. The ACWF is grateful for the partnership, which will enhance its efforts in promoting breast cancer education.

Breast cancer is a threat to women around the world, according to Ambassador Verveer, Ambassador-at-Large for Global Women’s Issues at the U.S. Department of State. She applauded the ACWF, Susan G. Komen for the Cure® and Goldman Sachs in initiating this public-private partnership to provide international knowledge and resources to women in need.

Ambassador Nancy G. Brinker, Komen’s founder and CEO, said as the world’s leading breast cancer organization, Komen is deeply appreciative of the collaboration with the ACWF and Goldman Sachs, with the support of the U.S. State Department. Komen observes from its three decades of breast cancer advocacy that when people work together to provide information, screening and treatment, significant progress can be made against breast cancer.

The alliance will build on a breast cancer screening program established between the ACWF and China’s Ministry of Health.



CONTACT:

Goldman Sachs
Joe Snodgrass, 212-902-5400
or
For Susan G. Komen for the Cure
Alyssa Goldfarb, 202-729-4077
[email protected]

KEYWORDS:   United States  Asia Pacific  North America  China  New York

INDUSTRY KEYWORDS:   Education  Other Education  Health  Oncology  Philanthropy  Professional Services  Banking  Finance  Other Professional Services  Research  Other Science  Science  Foundation

MEDIA:

Suggested Articles

At one point, Novartis even offered up $90 apiece for the inclisiran developer but would later say even $85 was too much, a securities filing shows.

Sanofi spent months hyping its Tuesday investor event, and new CEO Paul Hudson certainly laid out a different vision for the drugmaker at the confab.

After more than 10 years as partners, Sanofi and Regeneron are splitting up their deal to comarket PCSK9 med Praluent and immunology drug Kevzara.